Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Condition: Castration Resistant Metastatic Prostate Cancer
NCT04363164
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.